Thalys Medical Technology Group Corporation (SHA:603716)
China flag China · Delayed Price · Currency is CNY
15.95
-0.29 (-1.79%)
Jun 8, 2026, 3:00 PM CST

SHA:603716 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,4774,2381,3502,1262,1152,800
Market Cap Growth
69.46%213.84%-36.50%0.51%-24.45%-14.23%
Enterprise Value
3,7594,6432,3053,1633,3373,959
Last Close Price
16.2420.557.2211.0911.0414.39
Forward PE
-35.8235.8235.8235.8235.82
PS Ratio
3.583.940.751.060.921.08
PB Ratio
3.534.681.401.621.411.61
P/TBV Ratio
3.544.711.572.001.722.04
P/FCF Ratio
--17.6825.00--
P/OCF Ratio
--13.5616.8975.23-
EV/Sales Ratio
3.494.311.271.581.451.52
EV/EBITDA Ratio
--52.6194.1973.7923.73
EV/EBIT Ratio
--300.85--41.75
EV/FCF Ratio
-564.80-30.1837.19--
Debt / Equity Ratio
0.380.500.960.800.940.92
Debt / EBITDA Ratio
--15.3218.8220.418.37
Debt / FCF Ratio
--12.1112.34--
Net Debt / Equity Ratio
0.240.360.740.590.680.64
Net Debt / EBITDA Ratio
-5.80-8.5116.3322.9722.346.68
Net Debt / FCF Ratio
-35.93-7.419.379.07-38.10-5.75
Asset Turnover
0.480.470.590.550.560.63
Inventory Turnover
3.243.084.444.244.214.75
Quick Ratio
1.241.101.231.421.321.53
Current Ratio
1.611.421.521.721.611.87
Return on Equity (ROE)
-21.47%-21.58%-16.99%-11.15%-11.74%-2.17%
Return on Assets (ROA)
-2.06%-1.76%0.15%-0.32%-0.24%1.44%
Return on Invested Capital (ROIC)
-5.40%-4.48%0.41%-0.82%-0.58%3.51%
Return on Capital Employed (ROCE)
-6.50%-7.00%0.50%-1.00%-0.70%3.70%
Earnings Yield
-6.05%-4.89%-15.50%-7.46%-7.27%-1.77%
FCF Yield
-0.19%-1.03%5.66%4.00%-1.25%-6.92%
Buyback Yield / Dilution
0.57%-3.61%0.73%0.62%1.73%0.23%
Total Shareholder Return
0.57%-3.61%0.73%0.62%1.73%0.23%